After years of stagnation, Gilead is betting that a twice-yearly HIV shot can restart its growth engine.

Biotech companies are using a new set of artificial intelligence products to hasten drug discovery and other scientific ...

The Radford University Board of Supervisors worked together to unanimously approve a proposal to create a new undergraduate ...

On the occasion of National Bioproduction and Biomedicines Day (JNBB), which enjoys the high patronage of the President of ...

Malvern biotechnology company Fujirebio Diagnostics has developed a revolutionary new test to diagnose Alzheimer’s disease, ...

For all the attention on U.S.-China AI competition, new studies point to China’s rapid rise in biotechnology, especially for ...

The investment bank says funding was down 57% last month, to $2.7 billion, and argues the new administration’s FDA ...

A new paper published in Nature on June 4 shines light on how an enigmatic part of male aging—the loss of Y chromosomes—is ...

The Association for Diagnostics and Laboratory Medicine (ADLM) has awarded Tulane University research scientist Tony Hu, PhD, ...

A youth organisation on Thursday introduced a job-matching platform for the biotechnology sector, saying young people are ...

Drug developers aren’t expected to come back to the US equity markets in full force until next year — lagging other ...